THAR – tharimmune, inc. (US:NASDAQ)
Stock Stats
News
Tharimmune to Present at the Microcap Conference 2025
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update [Yahoo! Finance]
Tharimmune Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis and Provides a Business Update
Tharimmune, Inc. (NASDAQ: THAR) was upgraded by analysts at RODMAN&RENSHAW to a "strong-buy" rating.
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs [Yahoo! Finance]
Form 4 Tharimmune, Inc. For: Jan 13 Filed by: MILBY RANDY
Form 4 Tharimmune, Inc. For: Jan 14 Filed by: Appajosyula Sireesh
Form 424B3 Tharimmune, Inc.
Form EFFECT Tharimmune, Inc.
Form 4 Tharimmune, Inc. For: Dec 19 Filed by: MILBY RANDY
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.